Clinical Trial Update: Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the safety and pharmacokinetics of LPX-TI641 in patients with rheumatoid arthritis and psoriatic arthritis, currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• LPX-TI641

Snippet

Sponsor: LAPIX Therapeutics Inc. | Conditions: Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) | Phase 1 | Status: RECRUITING